Research Output per year
Vosaroxin is a novel topoisomerase-II inhibitor with efficacy in relapsed and refractory acute myeloid leukaemiaHotinski, A. K., Lewis, I. D. & Ross, D. M., 1 Jun 2015, In : EXPERT OPINION ON PHARMACOTHERAPY. 16, 9, p. 1395-1402 8 p.
Research output: Contribution to journal › Review article
15 Citations (Scopus)